RapidAI
AI-powered imaging platform for vascular and neurovascular clinical decision support.
What they do
The company provides advanced stroke and aneurysm imaging software that utilizes AI to analyze CT and MRI scans. Used globally in thousands of hospitals, the software helps multidisciplinary care teams coordinate vascular emergency treatments rapidly.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- San Mateo, USA
- Region
- North America
- Founded
- 2011
- Total funding
- $100M raised
Notable investors: Vista Credit Partners, Landy Venture Partners.